Review
Jul 2026
Advances in antibody-drug conjugate-based combination therapy strategies for non-small cell lung cancer
This review looks at ADC-based combination strategies in NSCLC, grouped by key molecular targets such as Trop-2, HER2, HER3, c-Met, B7-H3, CEACAM5, and ITGβ6, along with bispecific ADCs.
Yunqi Mi, Shan Wang, Yuhao Wang et al.
· Expert Opinion on Biological... · 0 citations